Interesting facts
              Interesting Facts about 5-Methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine
5-Methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine is a fascinating compound that belongs to the class of bicyclic heterocycles. Its unique structure results in several noteworthy aspects:
- Structural Complexity: The compound is characterized by a complex bicyclic system that comprises both an aromatic and a non-aromatic ring. This structural interaction influences its chemical behavior significantly.
- Therapeutic Potential: Compounds like this one are often studied for their potential in medicinal chemistry. The presence of the benzoxazocine moiety may contribute to intriguing pharmacological activities that warrant further exploration.
- Substituent Influence: The methyl and phenyl substituents play a crucial role in modulating the compound's chemical properties, including its reactivity and molecular interactions. Such variations are essential when investigating structure-activity relationships in drug design.
- Analytical Challenges: Molecules with such intricate structures can present analytical challenges. Techniques like NMR (Nuclear Magnetic Resonance) and mass spectrometry are vital for elucidating their structures and understanding their behavior in different environments.
The synthesis of 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine also generates much interest among chemists due to the methodologies involved in constructing complex cyclic systems. As research continues, this compound may uncover new applications, particularly in pharmacology and materials science. As the renowned chemist Marie Curie once said, "Nothing in life is to be feared, it is only to be understood." The multifunctionality of such compounds encourages scientists to delve deeper into their mysteries for a greater understanding.
Synonyms
          nefopam
          13669-70-0
          Fenazoxine
          5-Methyl-1-phenyl-3,4,5,6-tetrahydro-1H-benzo[f][1,4]oxazocine
          Nefopamum
          1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-
          5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine
          Nefopam [INN:BAN]
          Nefopamum [INN-Latin]
          EINECS 237-148-2
          Nefopam (INN)
          CHEBI:88318
          4UP8060B7J
          NEFOPAM [INN]
          NEFOPAM [MI]
          NEFOPAM [WHO-DD]
          DTXSID2048535
          3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocin
          5-Methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine
          3-Methyl-7-phenyl-6-oxa-3-azabicyclo[6.4.0]dodeca-8,10,12-triene
          Nefopamum (INN-Latin)
          3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine
          UNII-4UP8060B7J
          Spectrum_001376
          Prestwick0_000229
          Prestwick1_000229
          Prestwick2_000229
          Prestwick3_000229
          Spectrum2_001416
          Spectrum3_000912
          Spectrum4_001011
          Spectrum5_001349
          Oprea1_350502
          SCHEMBL23646
          BSPBio_000277
          KBioGR_001501
          KBioSS_001856
          DivK1c_000384
          SPECTRUM1501137
          SPBio_001492
          SPBio_002198
          BPBio1_000305
          CHEMBL465026
          DTXCID8028002
          CHEBI:88316
          HMS501D06
          KBio1_000384
          KBio2_001856
          KBio2_004424
          KBio2_006992
          KBio3_001884
          N02BG06
          NINDS_000384
          HMS1921J03
          HMS2092F11
          Pharmakon1600-01501137
          KEA01182
          RDA46382
          BDBM50237616
          CCG-38969
          NSC757856
          STL483795
          AKOS001582723
          AKOS016842440
          DB12293
          IDI1_000384
          NCGC00094906-01
          NCGC00094906-02
          NCGC00094906-03
          NCGC00094906-07
          AC-12146
          SBI-0051651.P002
          DB-042351
          AB00052213
          NS00004218
          D08258
          AB00052213_09
          AB00052213_10
          A807114
          EN300-18537040
          Q599052
          SR-01000388442-3
          BRD-A78877355-001-03-0
          BRD-A78877355-003-03-6
          BRD-A78877355-003-11-9
          3,4,5,6-Tetrahydro-5-methyl-2-phenyl-1H-2,5-benzoxazocine
          5-Methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine #
          rac-5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine
          1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-(8CI,9CI)
          237-148-2
              
Solubility of 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine
The solubility of 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine (C16H17NO) in various solvents is a fascinating topic. This compound, due to its unique structure, exhibits specific solubility characteristics that can influence its behavior in chemical reactions and applications.
Key Points About Solubility:
In conclusion, understanding the solubility of 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine is crucial for applications in pharmaceuticals and material science. As the adage goes, "Like dissolves like," which serves as a guideline for predicting how this compound interacts with various solvents. Always consider consulting solubility charts or conducting empirical tests for accurate solubility assessments.